Related Experiment Videos
[Coronary laser angioplasty: clinical value and experimental progress]
1Medizinische Klinik, Abteilung III Eberhard-Karls-Universität Tübingen.
Zeitschrift Fur Kardiologie
|January 1, 1996
Summary
Excimer laser angioplasty is feasible and safe for coronary artery disease, but complications and restenosis limit its use. Future laser devices aim for better ablation with less tissue injury.
Area of Science:
- Cardiovascular Medicine
- Medical Technology
- Interventional Cardiology
Background:
- Excimer laser angioplasty (ELA) has been utilized in treating coronary artery disease (CAD).
- Over 10,000 patients underwent ELA between 1988 and 1995.
- Data suggest ELA is a feasible and safe interventional technique.
Purpose of the Study:
- To evaluate the efficacy and limitations of excimer laser angioplasty in CAD.
- To explore reasons for ELA not being a stand-alone procedure.
- To investigate the mechanisms of vessel injury and potential improvements.
Main Methods:
- Review of clinical data from approximately 10,000 patients treated with ELA.
- Analysis of angiographic and clinical follow-up studies.
- Examination of experimental results on laser-tissue interactions.
Main Results:
- ELA is feasible and safe but often requires adjunctive procedures due to insufficient results or complications.
- Complications include abrupt vessel closure, dissection, and perforation.
- ELA does not reduce the incidence of restenosis.
- Experimental findings highlight pressure waves and bubble formation as sources of vessel trauma.
Conclusions:
- While ELA is safe, its limitations in achieving optimal results and preventing restenosis are significant.
- Understanding laser-induced tissue injury mechanisms is crucial for developing improved devices.
- Future laser technologies emitting in the mid-infrared spectrum are expected to enhance ablation efficiency while minimizing thermal and acoustic damage.